Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FM003
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,232
Award facts
- Contract value 100% obligated
- $27,231.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $27,231.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for pharmaceutical products and medical supplies, with an ultimate completion date of November 12, 2025. This delivery order, issued without set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs.
This delivery order supports DLA's critical medical supply chain operations serving military and veteran healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates extensive capabilities in delivering a comprehensive range of pharmaceutical products, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed-price structure and competitive award reflect the company's established capability to meet federal procurement requirements. The delivery order is part of DLA's broader Pharmaceutical Prime Vendor Global Program, which is transitioning to Generation V contracts with planned multiple regional awards to ensure robust pharmaceutical supply support across the Department of Defense and related federal healthcare entities.
Quick answers
Who was awarded contract SPE2DU26FM003?
SPE2DU26FM003 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DU26FM003 worth?
The government has obligated $27,232 on SPE2DU26FM003.
Is contract SPE2DU26FM003 an order under another contract?
Yes. SPE2DU26FM003 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FM003 competed?
The extent of competition for SPE2DU26FM003 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award